Microbiomes and Integrated Multi-omics in Health and Disease

A topical collection in Microorganisms (ISSN 2076-2607). This collection belongs to the section "Microbiomes".

Viewed by 1380

Editor


E-Mail Website
Collection Editor
Clinical Hospital of Porto Alegre (HCPA), affiliated with the Federal University of Rio Grande do Sul, Porto Alegre 91501-970, Brazil
Interests: microbiome; molecular microbiology; metagenomics; omics; biostatistics; next-generation sequencing; clinical research; bioinformatics; biotechnology; system biology; grand challenges
Special Issues, Collections and Topics in MDPI journals

Topical Collection Information

Dear Colleagues,

The intricate and dynamic relationship between hosts and their associated microbiomes has emerged as a critical factor in understanding the pathogenesis and progression of various human diseases. Recent advancements in high-throughput omics technologies have enabled a more comprehensive understanding of this complex system, providing novel insights into the molecular mechanisms underlying host–microbiome interactions and their influence on health and disease.

Genomic sequencing has enabled the comprehensive characterization of microbial communities and their functional capabilities within the host environment. Transcriptomic analysis has revealed dynamic changes in gene expression patterns, shedding light on the signaling networks and pathways involved in host–microbiome crosstalk. Proteomic studies have identified the key proteins mediating various processes, including immune responses and metabolic exchanges. Furthermore, metabolomic profiling has elucidated the metabolic interactions and signaling molecules that shape the host–microbiome symbiosis and its impact on physiology and disease progression. The integration of these powerful omics approaches has provided a holistic understanding of the complex and multifaceted host–microbiome system, paving the way for developing targeted interventions and personalized healthcare strategies to address various health conditions.

This collection aims to showcase cutting-edge research employing integrative multi-omics approaches to elucidate the complex host–microbiome interactions in health and disease. We invite submissions that explore the application of genomics, transcriptomics, proteomics, metabolomics, and other emerging omics techniques to unravel the underlying mechanisms governing host–microbiome symbiosis and how this relationship collectively shapes disease susceptibility, progression, and outcomes. We hope that these discoveries will provide new perspectives and valuable insights to inform the development of more effective therapeutic and intervention strategies.

Some topics of interest include, but are not limited to, the following:

  • Integrated multi-omics studies elucidating the molecular cross-talk between hosts and their microbiomes;
  • Identification of microbial and host-derived biomarkers for disease prediction, diagnosis, and monitoring;
  • Novel computational and bioinformatic tools for integrative host–microbiome omics analysis;
  • Translational applications of integrated host–microbiome omics in personalized medicine and targeted therapeutic interventions;
  • Methodological advancements in sample preparation, data acquisition, and multi-omics data integration;
  • Challenges and solutions in the interpretation of complex host–microbiome omics datasets;
  • Application of machine learning and artificial intelligence for multi-omics data analysis;
  • Case studies demonstrating the potential of multi-omics approaches to understand health, disease, and host–microbiome interactions;
  • Unraveling the host–microbiome interactome through multi-omics approaches;
  • Ethical and regulatory considerations in the application of host–microbiome omics for human health.

Prof. Dr. Pabulo H. Rampelotto
Collection Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the collection website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bioinformatics
  • biomarker discovery
  • integrative data analysis
  • interactome
  • host–microbiome interactions
  • omics datasets
  • omics technologies
  • metabolomics
  • metagenomics
  • metaproteomics
  • microbiome-associated diseases
  • molecular crosstalk
  • multi-omics
  • personalized medicine
  • translational applications

Published Papers (1 paper)

2025

13 pages, 983 KiB  
Review
An Overview of the Skin Microbiome, the Potential for Pathogen Shift, and Dysbiosis in Common Skin Pathologies
by Anita Smith, Roberta Dumbrava, Noor-Ul-Huda Ghori, Rachael Foster, James Campbell, Andrew Duthie, Gerard Hoyne, Marius Rademaker and Asha C. Bowen
Microorganisms 2025, 13(1), 54; https://doi.org/10.3390/microorganisms13010054 - 1 Jan 2025
Viewed by 932
Abstract
Recent interest in the diverse ecosystem of bacteria, fungi, parasites, and viruses that make up the skin microbiome has led to several studies investigating the microbiome in healthy skin and in a variety of dermatological conditions. An imbalance of the normal skin flora [...] Read more.
Recent interest in the diverse ecosystem of bacteria, fungi, parasites, and viruses that make up the skin microbiome has led to several studies investigating the microbiome in healthy skin and in a variety of dermatological conditions. An imbalance of the normal skin flora can cause some skin diseases, and current culture techniques are often unable to detect a microorganism to further our understanding of the clinical–microbiological correlates of disease and dysbiosis. Atopic dermatitis and rosacea are presentations that GPs often manage that may have an infective or microbiological component and can be challenging to treat. We aim to discuss the implications of the skin microbiome including the impact of dysbiosis on conditions such as these. We will also discuss some clinical pearls for initial and future directions of the management of conditions such as atopic dermatitis, rosacea, and hidradenitis suppurativa. Further research using culture-independent techniques is needed for conditions involving microbial dysbiosis to advance our knowledge of skin disease pathophysiology and guide future management. Full article
Show Figures

Figure 1

Back to TopTop